Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer
Condition(s):Xerostomia; Asialia; Hyposalivation; Mouth DrynessLast Updated:January 27, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):Xerostomia; Asialia; Hyposalivation; Mouth DrynessLast Updated:January 27, 2020Terminated
Condition(s):Ischemic StrokeLast Updated:January 3, 2024Recruiting
Condition(s):Hair Loss; Hair ThinningLast Updated:October 27, 2021Withdrawn
Condition(s):Xerostomia Due to Hyposecretion of Salivary Gland; pH; Saliva; Quality of LifeLast Updated:August 2, 2018Completed
Condition(s):PrehypertensionLast Updated:March 7, 2013Unknown status
Condition(s):Chronic Anal FissureLast Updated:January 14, 2020Terminated
Condition(s):Overweight and Obesity; High Blood PressureLast Updated:April 1, 2020Completed
Condition(s):Acne; Eczema; Skin AgingLast Updated:February 29, 2024Not yet recruiting
Condition(s):High-Normal Blood PressureLast Updated:February 1, 2024Completed
Condition(s):Concentration Ability Impaired; Mental FatigueLast Updated:March 6, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.